from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0370c/-

LFCtreatmentdescriptionclass of inhibitor

-1.046

Amikacinug/mL Amikacintranslation

-0.545

Cap5-10ug/mL Capreomycintranslation

-0.715

Rox10-50 ug/mL Roxithromycintranslation

-0.917

SM2-5 ug/mL Streptomycintranslation

-0.588

Tet5-10 ug/mL Tetracyclinetranslation

-0.448

Rif0.2-5ug/mL Rifampicintranscription

-0.134

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.564

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.896

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.049

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.126

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.842

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.682

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.500

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.601

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.473

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.104

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.239

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.162

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.408

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.141

KCN5-20 ug/mL Potassium cyaniderespiration

-0.380

NaN30.2-2 mM Sodium aziderespiration

-1.394

Nigericin50 uM Nigericinrespiration

0.270

TRC10-150 ug/mL Triclosanrespiration

1.305

TRZ10-25 ug/mL Thioridazinerespiration

-0.264

Valinomycin0.5-10 uM Valinomycinrespiration

-2.647

ZnSO42 mM ZnSO4respiration

-0.501

menadione6-10 ug/mL Menadionerespiration

0.574

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.673

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.005

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.175

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.740

NRP_1Non-replicating persistence stage 1dosRassociated

-0.268

Amp0.2mg/mL AmpicillincellWall

-0.462

Cephalexin20-100 ug/mL CephalexincellWall

-0.913

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.452

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.415

EMB10-20 ug/mL EthambutolcellWall

-1.739

Eta12-40 ug/mL EthionamidecellWall

-1.474

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.738

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.027

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.760

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.542

BZA0.12 mg/mL BenzamidearomaticAmides

0.826

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.033

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.391

H2O24 mM hydrogen peroxideDNAdamaging

0.122

Levo10 ug/mL LevofloxacinDNAdamaging

0.366

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.004

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.839

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.133

UVUV-irradiationDNAdamaging

1.147

ARP41-4 ug/mL Antitubercular compound ARP4?

0.118

Antimycin12.5-50 ug/mL Antimycin A?

-1.079

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.826

PA_110-50 ug/mL Antitubercular compound PA-1?

1.360

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.770

PA8240.2-2 ug/mL PA-824?

0.097

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.054

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.926

Verapamil50 uM Verapamil?

-0.709

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.916

methoxatin10-20 ug/mL Methoxatin?